Cambridge Study Shows Neural Stem Cell Grafts Can Restore Myelin in Mouse Model of Progressive MS

A recent study conducted by researchers at Cambridge University has demonstrated the potential of neural stem cell grafts to restore myelin in the central nervous system. The research, which utilized a mouse model of progressive multiple sclerosis (MS), indicates that therapies based on neural stem cells may offer a promising avenue for treating chronic demyelinating disorders, including advanced stages of MS.

The study focused on the ability of neural stem cell grafts to repair damage caused by the loss of myelin, a protective sheath surrounding nerve fibers that is often degraded in individuals with multiple sclerosis. Researchers observed that these grafts facilitated the regeneration of myelin in affected areas within the central nervous system. The findings highlight the therapeutic potential of stem cell-based approaches for addressing conditions characterized by persistent demyelination, such as progressive MS. Further investigation will be necessary to determine how these results could translate into clinical applications for human patients.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: July 7, 2025

Related posts:

Generic Drug Approval: FDA Review Process Can Take Up To 36 Months Globaldata Tracks HTA Decisions and New Drug Market Entry in 5EU Eisai Wins Patent Dispute Blocking Shilpa Medicare’s Generic Lenvatinib Approval Until 2036 Carinne Brouillon Discusses Cross-Functional Collaboration Strategies in December 2023 Interview

Author

Mark Chiang